| Title | Guidance: Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics |
| ToC Doc | Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics |
| Docket Number | 2024-13271 |
| Type | Notice |
| Subject | Guidance: Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics |
| Publication Date | 2024-06-17 |
| Last Updated Date | 2024-06-14 08:15:10 -0400 |
| Last Public Inspection | 2024-06-14 |
| Filed At | 2024-06-14T08:45:00.000-04:00 |
| 2024-13271_PI.pdf (106337 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 5 |
| Filing Type | regular |
| Agencies | Food and Drug Administration |
You can find the raw source document below...